featured
New Data on Antibody-Drug Conjugates and Other Novel Compounds for Second-Line Urothelial Carcinoma Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: